CTRI/2020/12/029904
Not yet recruiting
未知
A Comparative Study of Efficacy and Safety of Oral Fluconazole Versus 5% Amrolfine Nail Lacquer in Patients of Onychomycosis
Dr Ruchir M Bhatt0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: L609- Nail disorder, unspecified
- Sponsor
- Dr Ruchir M Bhatt
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with any age.
- •Patients suffering from at least one Toenail onychomycosis with or without matrix involvement.
Exclusion Criteria
- •Pregnant or lactating women
- •Suffering from other nail conditions (e.g., psoriasis) which might interfere in the interpretation of results
- •Those on treatment with a topical or systemic antifungal during 4 weeks preceding screening.
- •with cardiac, hepatic, or renal comorbidities
- •those having history of hypersensitivity to any of the drugs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Study to compare the effectiveness and safety of two drugs in atopic dermatitis in childreCTRI/2024/02/063274IMS and SUM Hospital
Completed
Not Applicable
Effectiveness and safety of oral and intralesional tranexamic acid in treatment of melasmaHealth Condition 1: L811- ChloasmaHealth Condition 2: O- Medical and SurgicalCTRI/2021/08/035350Department of Dermatology42
Not yet recruiting
Phase 4
A study to compare efficacy and safety of levocetrizine versus levocetrizine alongwith probiotic in allergic rhinitis patientHealth Condition 1: J309- Allergic rhinitis, unspecifiedCTRI/2023/11/059620Shujauddin
Not yet recruiting
Phase 2
Research on Cheep (Pityriasis Versicolor) in Unani medicineHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2023/06/053546ational Institute of Unani Medicine
Completed
Phase 4
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple SclerosisIRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60